Intranasal brain delivery of cationic nanoemulsion-encapsulated TNFα siRNA in prevention of experimental neuroinflammation

S Yadav, SK Gandham, R Panicucci… - … , Biology and Medicine, 2016 - Elsevier
Neuroinflammation is a hallmark of acute and chronic neurodegenerative disorders. The
main aim of this study was to evaluate the therapeutic efficacy of intranasal cationic …

Comparative biodistribution and pharmacokinetic analysis of cyclosporine-A in the brain upon intranasal or intravenous administration in an oil-in-water nanoemulsion …

S Yadav, F Gattacceca, R Panicucci… - Molecular …, 2015 - ACS Publications
The main objective of this study was to evaluate comparative biodistribution and pharmacokinetics
of cyclosporine-A (CsA) following intranasal (IN) administration versus intravenous (IV…

Developability assessment in pharmaceutical industry: An integrated group approach for selecting developable candidates

V Saxena, R Panicucci, Y Joshi, S Garad - Journal of pharmaceutical …, 2009 - Elsevier
This article describes the role and responsibilities of the Developability Assessment Group (DAG),
a pharmaceutical Research and Development (R&D) subgroup, which supports drug …

Selection of oral bioavailability enhancing formulations during drug discovery

…, RM Dannenfelser, R Panicucci… - Drug development …, 2012 - Taylor & Francis
The objective of this paper was to identify oral bioavailability enhancing approaches for a
poorly water-soluble research compound during drug discovery stages using minimal amounts …

Novel coprocessed excipients composed of lactose, HPMC, and PVPP for tableting and its application

…, X Lin, Y Feng, X Kou, S Babu, R Panicucci - International journal of …, 2015 - Elsevier
New coprocessed excipients composed of α-lactose monohydrate (a filler), HPMC E3 (a
binder), and PVPP (a superdisintegrant) were developed by spray drying in this study to …

[HTML][HTML] A versatile polymer micelle drug delivery system for encapsulation and in vivo stabilization of hydrophobic anticancer drugs

…, T Costich, B Burke, H Skaff, R Panicucci… - Journal of drug …, 2012 - hindawi.com
Chemotherapeutic drugs are widely used for the treatment of cancer; however, use of these
drugs is often associated with patient toxicity and poor tumor delivery. Micellar drug carriers …

Preclinical development for suspensions

S Garad, J Wang, Y Joshi, R Panicucci - … Suspensions: From Formulation …, 2009 - Springer
This chapter summarizes the significance of suspension in preclinical development. Majority
of the preclinical studies are carried out using suspension. Therefore, it is important to know …

[HTML][HTML] Hydrogen bonding: Between strengthening the crystal packing and improving solubility of three haloperidol derivatives

H Saluja, A Mehanna, R Panicucci, E Atef - Molecules, 2016 - mdpi.com
The purpose of this study is to confirm the impact of polar functional groups on inter and intra-molecular
hydrogen bonding in haloperidol (HP) and droperidol (DP) and, hence, their …

Co-crystal formation based on structural matching

…, C Capacci-Daniel, S Garad, R Panicucci… - European Journal of …, 2016 - Elsevier
A co-crystal is defined as a single crystalline structure composed of two or more components
with no proton transfer which are solid at room temperature. Our group has come up with …

[HTML][HTML] NRX-101 (D-Cycloserine+ Lurasidone) Is Active against Drug-Resistant Urinary Pathogens In Vitro

MT Sapko, M Manyak, R Panicucci, JC Javitt - Antibiotics, 2024 - mdpi.com
D-Cycloserine (DCS) is a broad-spectrum antibiotic that is currently FDA-approved to treat
tuberculosis (TB) disease and urinary tract infection (UTI). Despite numerous reports showing …